CN116949197A - Establishment of four common cryptosporidium RAA detection methods - Google Patents
Establishment of four common cryptosporidium RAA detection methods Download PDFInfo
- Publication number
- CN116949197A CN116949197A CN202311080419.8A CN202311080419A CN116949197A CN 116949197 A CN116949197 A CN 116949197A CN 202311080419 A CN202311080419 A CN 202311080419A CN 116949197 A CN116949197 A CN 116949197A
- Authority
- CN
- China
- Prior art keywords
- cryptosporidium
- raa
- establishment
- primer
- parvum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000223935 Cryptosporidium Species 0.000 title claims abstract description 107
- 238000001514 detection method Methods 0.000 title claims abstract description 30
- 230000035945 sensitivity Effects 0.000 claims abstract description 12
- 241000223936 Cryptosporidium parvum Species 0.000 claims description 55
- 230000003321 amplification Effects 0.000 claims description 39
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 39
- 241001223608 Cryptosporidium bovis Species 0.000 claims description 27
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 claims description 24
- 229940069446 magnesium acetate Drugs 0.000 claims description 24
- 235000011285 magnesium acetate Nutrition 0.000 claims description 24
- 239000011654 magnesium acetate Substances 0.000 claims description 24
- 239000013612 plasmid Substances 0.000 claims description 20
- 238000002474 experimental method Methods 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 238000011144 upstream manufacturing Methods 0.000 claims description 8
- 230000009977 dual effect Effects 0.000 claims description 6
- 238000003556 assay Methods 0.000 claims 2
- 241000218206 Ranunculus Species 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 108020004414 DNA Proteins 0.000 abstract description 43
- 102000018120 Recombinases Human genes 0.000 abstract description 5
- 108010091086 Recombinases Proteins 0.000 abstract description 5
- 101710126859 Single-stranded DNA-binding protein Proteins 0.000 abstract description 5
- 238000003745 diagnosis Methods 0.000 abstract description 5
- 102000052510 DNA-Binding Proteins Human genes 0.000 abstract description 4
- 101710116602 DNA-Binding protein G5P Proteins 0.000 abstract description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 abstract description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 abstract description 4
- 102000004190 Enzymes Human genes 0.000 abstract description 4
- 108090000790 Enzymes Proteins 0.000 abstract description 4
- 101710162453 Replication factor A Proteins 0.000 abstract description 4
- 101710176758 Replication protein A 70 kDa DNA-binding subunit Proteins 0.000 abstract description 4
- 101710176276 SSB protein Proteins 0.000 abstract description 4
- 230000009471 action Effects 0.000 abstract description 4
- 230000000295 complement effect Effects 0.000 abstract description 4
- 239000012634 fragment Substances 0.000 abstract description 2
- 230000035484 reaction time Effects 0.000 abstract description 2
- 241000244206 Nematoda Species 0.000 description 15
- 238000001502 gel electrophoresis Methods 0.000 description 15
- 238000003752 polymerase chain reaction Methods 0.000 description 9
- 241000224466 Giardia Species 0.000 description 8
- 241000235648 Pichia Species 0.000 description 7
- 208000008953 Cryptosporidiosis Diseases 0.000 description 6
- 210000001198 duodenum Anatomy 0.000 description 6
- 241000223996 Toxoplasma Species 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- 206010011502 Cryptosporidiosis infection Diseases 0.000 description 4
- 241000223997 Toxoplasma gondii Species 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 3
- 101150031823 HSP70 gene Proteins 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 241000243770 Bursaphelenchus Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000224467 Giardia intestinalis Species 0.000 description 2
- 241000235058 Komagataella pastoris Species 0.000 description 2
- 238000007397 LAMP assay Methods 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003239 susceptibility assay Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001480037 Microsporum Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000003250 oocyst Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 108700022487 rRNA Genes Proteins 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention belongs to the technical field of biological detection, and particularly relates to establishment of four common cryptosporidium RAA detection methods. The RAA technology mainly uses 3 enzymes of recombinase, single-stranded DNA binding protein and DNA polymerase, under the condition of constant temperature, the recombinase and a specific primer are combined to form a complex, after the primer searches complementary sequences on template DNA, the template DNA is melted under the action of the single-stranded DNA binding protein, and then a new DNA complementary strand pair is formed under the action of the DNA polymerase. After repeated tens of times, the number of new DNA chains increases exponentially, and amplified fragments which can be detected by the device can be obtained within one hour, and the whole reaction is simple and rapid. The RAA technology has the advantages of convenience in operation, short reaction time, high sensitivity, convenience in carrying, good stability and the like, can be popularized and used in a basic layer or a remote mountain area, and has great application potential and prospect in field rapid diagnosis.
Description
Technical Field
The invention belongs to the technical field of biological detection, and particularly relates to establishment of four common cryptosporidium RAA detection methods.
Technical Field
At present, it has been confirmed that there are at least 44 effective species of Cryptosporidium, whose genotypes exceed 120, which can infect a wide variety of vertebrates including mammals, reptiles, amphibians, birds and fish. Cryptosporidiosis is considered to be a significant cause of diarrhea in humans and animals worldwide. Cryptosporidium can be transmitted through food and water, and human or animal infection with Cryptosporidium is mainly through ingestion of contaminated food or water, so that the incidence and prevalence of Cryptosporidium disease are high in underdeveloped and developing countries. Cases of human cryptosporidium infection are mostly children, symptoms such as malnutrition, recurrent vomiting, hypoevolutism, abdominal pain, diarrhea and the like can appear after infection, and serious cases even cause death. Cattle are recognized as a main source of cryptosporidiosis of people and livestock, the total infection rate of Cryptosporidiosis of cattle in China is 15.5 percent, and great public health hidden danger exists, and meanwhile, no effective therapeutic drug exists at present, so that a rapid, accurate, simple and convenient detection method is very important for preventing the cryptosporidiosis.
The current detection methods for cryptosporidium include: etiology diagnosis and immunology diagnosis. Microscopic examination of fresh fecal samples is the most straightforward way to detect the presence of cryptosporidium pathogen. The method combining dyeing with microscopic examination is developed subsequently to improve the detection sensitivity, however, the microscopic examination method has larger workload, not only has low sensitivity and specificity, but also cannot accurately identify the species and genotype of Cryptosporidium. Because of the large amount of impurities such as fecal slag, grease and the like in the feces, professional technicians are required to identify the feces when the cryptosporidium microscopic examination is carried out on the feces, and false negative or false positive can be caused due to insufficient recognition of oocyst morphology and impurities. Immunological diagnostic techniques have been developed as alternatives to microscopic detection, including enzyme-linked immunosorbent assays (ELISA), indirect ELISA, immunofluorescence techniques, and dipstick tests. The immunological technology has the advantages of higher sensitivity and specificity compared with microscopic examination, simpler operation and the like, but can only be used for detecting whether the cryptosporidium infection exists, the genotype of the cryptosporidium can not be determined, and the occurrence of false positive is easily caused by non-specific reaction.
With the rapid development of molecular biology techniques, detection methods based on PCR technology in combination with DNA sequencing have led to a number of new detection techniques for the identification of Cryptosporidium species, including Polymerase Chain Reaction (PCR), PCR restriction fragment length polymorphism analysis (PCR-RFLP), real-time fluorescent quantitative PCR, nested PCR, multiplex PCR, loop-mediated isothermal amplification (LAMP), and the like. But the molecular biology method has the advantages of long time consumption, high requirements on instruments and equipment and technology, and difficulty in use and popularization in basic level and field diagnosis.
Disclosure of Invention
In order to solve the problems in the prior art, the invention adopts the following technical scheme:
the invention aims to provide a scheme for establishing RAA detection methods of four common Cryptosporidium.
It is another object of the present invention to provide the use of a method of RAA detection of Cryptosporidium in the detection of primary and on-site diagnosis of Cryptosporidium.
The Recombinase-mediated isothermal nucleic acid amplification (RAA) technology mainly uses 3 enzymes of Recombinase, single-stranded DNA binding protein (Single-stranded DNA binding, SSB) and DNA polymerase, wherein under the condition of constant temperature, the Recombinase and a specific primer are combined to form a complex, the primer searches complementary sequences on template DNA, the template DNA is melted under the action of the Single-stranded DNA binding protein, and a new DNA complementary strand pair is formed under the action of the DNA polymerase. After several tens of repetitions, the number of new DNA strands grows exponentially, and amplified fragments that can be detected by the device are obtained within one hour.
The invention has the beneficial effects that:
the whole reaction provided by the invention can react at normal temperature, is simple and quick, and has high sensitivity and strong specificity. The recombinant enzyme derived from bacteria or fungi used in the RAA technology is low in cost, and the interaction of various enzymes replaces the common PCR thermal cycle melting cycle process, so that the reaction time is greatly reduced, and the requirement on equipment is reduced.
Drawings
The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description serve to explain the principles of the invention.
FIG. 1 shows RAA amplification of Cryptosporidium angustifolium under different temperature conditions: m:2000bp DNA molecular mass standard; 1-7:36-42 ℃;
FIG. 2 shows RAA amplification of Cryptosporidium angustifolium under different amounts of primer conditions: m:2000bp DNA molecular mass standard; 1-6: 0.5-5. Mu.L;
FIG. 3 shows RAA amplification of Cryptosporidium angustifolium under varying amounts of magnesium acetate I: m:2000bp DNA molecular mass standard; 1-6: 1.5-4. Mu.L;
FIG. 4 shows the results of a Cryptosporidium angustifolium RAA plasmid susceptibility test: m:2000bp DNA molecular mass standard; 1-4:2.61×10 4 Copy/. Mu.L, 2.61X 10 3 Copy/. Mu.L, 2.61X 10 2 Copy/. Mu.L, 2.61X 10 1 Copy/. Mu.L;
FIG. 5 is a graph showing the specificity verification of Cryptosporidium angustifolium RAA: m:2000bp DNA molecular mass standard; 1-10: cryptosporidium angustiforme, cryptosporidium parvum, cryptosporidium nii, cryptosporidium parvum, pichia, giardia duodenum, toxoplasma, coccidium, capillary nematodes and roundworms;
FIG. 6 shows RAA amplification of Cryptosporidium parvum under different temperature conditions: m:2000bp DNA molecular mass standard; 1-7:36-42 ℃;
FIG. 7 shows RAA amplification of Cryptosporidium parvum under varying amounts of primer conditions: m:2000bp DNA molecular mass standard; 1-5: 0.5-4. Mu.L;
FIG. 8 shows RAA amplification of Cryptosporidium parvum under varying amounts of magnesium acetate I: m:2000bp DNA molecular mass standard; 1-5:1.5-3.5 mu L;
FIG. 9 shows the results of a Cryptosporidium parvum RAA plasmid susceptibility test: m:2000bp DNA molecular mass standard; 1-4:2.94×10 4 Copy/. Mu.L, 2.94X10 3 Copy/. Mu.L, 2.94X10 2 Copy/. Mu.L, 2.94X10 1 Copy/. Mu.L;
FIG. 10 shows the specificity verification of Cryptosporidium parvum RAA method: m:2000bp DNA molecular mass standard; 1-10: cryptosporidium parvum, cryptosporidium angustiforme, cryptosporidium nii, cryptosporidium parvum, pichia, giardia, toxoplasma, coccidium, capillary nematodes, roundworms;
FIG. 11 shows RAA amplification of Cryptosporidium bovis and Cryptosporidium ruihni under different temperature conditions: m:2000bp DNA molecular mass standard; 1-7:36-42 ℃; a: cryptosporidium bovis; b: cryptosporidium elegans;
FIG. 12 shows RAA amplification of Cryptosporidium bovis and Cryptosporidium ruihni under different amounts of primer conditions: m:2000bp DNA molecular mass standard; 1-5: 0.5-4. Mu.L; a: cryptosporidium bovis; b: cryptosporidium elegans;
FIG. 13 is RAA amplification of Cryptosporidium bovis and Cryptosporidium ruihni under varying amounts of magnesium acetate I: m:2000bp DNA molecular mass standard; 1-5:1.5-3.5 mu L; a: cryptosporidium bovis; b: cryptosporidium elegans;
FIG. 14 shows the results of experiments on the sensitivity of Cryptosporidium bovis and Cryptosporidium ruimachine RAA plasmids: m:2000bp DNA molecular mass standard; a: cryptosporidium bovis; 1-4:2.64×10 4 Copy/. Mu.L, 2.64X 10 3 Copy/. Mu.L, 2.64X 10 2 Copy/. Mu.L, 2.64X 10 1 Copy/. Mu.L; b: cryptosporidium elegans; 1-4: 2.24X10 4 Copy/. Mu.L, 2.24X10 3 Copy/. Mu.L, 2.24X10 2 Copy/. Mu.L, 2.24X10 1 Copy/. Mu.L;
FIG. 15 is a graph showing the specificity verification of Cryptosporidium bovis and Cryptosporidium ruimachine RAA: m:2000bp DNA molecular mass standard; a: cryptosporidium bovis; 1-10: cryptosporidium bovis, cryptosporidium angustifolium, cryptosporidium parvum, cryptosporidium ruthenicum, microsporum pichia, giardia duodenum, toxoplasma gondii, coccidium, capillary nematodes, roundworms; b: cryptosporidium elegans; 1-10: cryptosporidium elegans, cryptosporidium angustiforme, cryptosporidium parvum, cryptosporidium bovis, pichia, giardia duodenum, toxoplasma gondii, coccidium, capillary nematodes and roundworms;
FIG. 16 shows mRAA amplification of Cryptosporidium angustifolium and Cryptosporidium parvum under different temperature conditions: m:2000bp DNA molecular mass standard; 1-8:36-43 ℃;
FIG. 17 shows mRAA amplification of Cryptosporidium angustifolium and Cryptosporidium parvum primers in an amount of 1:1: m:2000bp DNA molecular mass standard; 1: the amount of the primer of the cryptosporidium angustiforme and the primer of the cryptosporidium parvum are 1 mu L;
FIG. 18 shows the amplification of mRAA by Cryptosporidium angustifolium and Cryptosporidium parvum different primers: m:2000bp DNA molecular mass standard; 1-7: cryptosporidium angustifolium: the usage amount of the cryptosporidium parvum primers is 0.5:1, 0.75:1, 1:1, 1:1.25, 1:1.5, 1:1.75 and 1:2 respectively;
FIG. 19 shows mRAA amplification of Cryptosporidium angustiforme and Cryptosporidium bovis under varying amounts of magnesium acetate I: m:2000bp DNA molecular mass standard; 1-5:1.5-3.5 mu L;
FIG. 20 shows the results of an experiment for sensitivity of Cryptosporidium angustifolium and Cryptosporidium parvum mRAA plasmids: m:2000bp DNA molecular mass standard; 1-4: the recombinant plasmid concentration was 10 in order 5 、10 4 、10 3 、10 2 Copy/. Mu.L amplification results;
FIG. 21 Cryptosporidium angustifolium and Cryptosporidium parvum RAA method specificity verification: m:2000bp DNA molecular mass standard; 1-12: cryptosporidium angustifolium and Cryptosporidium parvum mixture, cryptosporidium angustifolium, cryptosporidium parvum, cryptosporidium ruthenicum, cryptosporidium digitatum, giardia, coccidium, capillary nematodes and roundworms.
Description of the preferred embodiments
The present invention will be further described with reference to the following specific examples and drawings, but the present invention is not limited to the following examples.
In the following examples, the RAA reaction system was 50. Mu.L: 25 mu L of buffer solution, 0.5 to 5 mu L of forward and reverse primers (10 mu mol/L) and 1.5 to 4 mu L of DNA template (10) 1 ~10 4 Copy/. Mu.L), 1.5-4. Mu.L (280 mmol/L) of magnesium acetate I, and 50. Mu.L of distilled water, after being evenly mixed, the mixture is placed in a PCR instrument (or a water bath kettle) for constant-temperature amplification for 40min, and phenol/chloroform 1 is added: 1 mixture 50. Mu.L was mixed and 7. Mu.L was taken for gel electrophoresis identification.
Example 1
Establishment of cryptosporidium angustifolium RAA detection method
Optimization of the amplification conditions of Cryptosporidium angustifolium RAA:
primers were designed for the HSP70 gene locus of Cryptosporidium angustifolium (accession number: AB 089288), the upstream primer was 5 '-CCGTGCTTTGAGAAGATTAAGAACCCAGTG-3', and the downstream primer was 5 '-ACCTGCTGTTTCCAAACCTAAAGATAGTGG-3'. The reaction temperature, primers and amount of magnesium acetate I were varied to determine the optimal amplification conditions for RAA. The reaction components were added separately according to the reaction system, the reaction temperatures were set in the PCR apparatus at 36℃and 37℃and 38℃and 39℃and 40℃and 41℃and 42℃respectively, and the results of gel electrophoresis showed that the difference in the strip brightness was small at 36℃and 37℃and 38℃and that the strip at 40℃began to darken, as shown in FIG. 1, and 37℃was selected as the reaction temperature.
The primers were diluted to 10. Mu. Mol/L, the reaction temperature was 37℃and the concentrations of the primers (0.1. Mu. Mol/L, 0.2. Mu. Mol/L, 0.4. Mu. Mol/L, 0.6. Mu. Mol/L, 0.8. Mu. Mol/L) were varied, i.e., 0.5. Mu.L, 1. Mu.L, 2. Mu.L, 3. Mu.L, 4. Mu.L, 5. Mu.L of forward and reverse primers were added to the reaction system, respectively, and the gel electrophoresis showed that the bands became brighter as the amount of the primers increased, and that the 3. Mu.L and 4. Mu.L became darker as shown in FIG. 2, and the amount of the primers was 3. Mu.L (i.6. Mu. Mol/L, as the final concentration) was determined.
After adding 3. Mu.L of the primer at 37℃and the above reaction system, 1.5. Mu.L, 2. Mu.L, 2.5. Mu.L, 3. Mu.L, 3.5. Mu.L and 4. Mu.L of magnesium acetate I were added respectively, i.e., the final concentration of magnesium acetate was 8.4mmol/L,11.2mmol/L,14mmol/L,16.8mmol/L,19.6mmol/L and 22.4mmol/L, respectively, and the gel electrophoresis results showed that the bands of the amplified product became gradually brighter as the amount of magnesium acetate I increased, as shown in FIG. 3, the amount of magnesium acetate I was determined to be 3. Mu.L (i.e., the final concentration was 16.8 mmol/L).
Cryptosporidium angustifolium RAA sensitivity assay:
subjecting Cryptosporidium angustifolium plasmid standard to multiple dilution, and selecting concentration of 2.61×10 4 ~2.61×10 1 RAA amplification was performed using copy/. Mu.L as standard. As a result, as shown in FIG. 4, the RAA was able to detect at least 10 3 Copy/. Mu.L recombinant plasmid.
Cryptosporidium angustifolium RAA specificity experiments:
RAA amplification was performed using genomic DNA of Cryptosporidium angustiforme, cryptosporidium parvum, cryptosporidium Rugosae, pichia pastoris, giardia duodenum, toxoplasma gondii, coccidium, bursaphelenchus and ascariasis as templates, respectively, and the results are shown in FIG. 5: only when Cryptosporidium angustifolium DNA is used as a template, a single and brighter target band can be amplified, and other parasites do not amplify the band, so that the method has good specificity.
Example 2
Establishment of cryptosporidium parvum RAA detection method
Optimization of cryptosporidium parvum amplification conditions:
primers were designed for the cryptosporidium parvum SSU rRNA gene locus (accession number: MF 671870), with the upstream primer being 5 '-AAACTAATGCGAAAGCATTTGCCAAGGATG-3' and the downstream primer being 5 '-AAACTAATGCGAAAGCATTTGCCAAGGATG-3'. The reaction temperature, primers and amount of magnesium acetate I were varied to determine the optimal amplification conditions for RAA. The reaction temperature was set in the PCR apparatus at 36℃at 37℃at 38℃at 39℃at 40℃at 41℃at 42℃respectively, and the result of gel electrophoresis showed that the bands became gradually brighter as the temperature increased and that the bands became gradually darker when the temperature was higher to a certain level, and that the bands were brighter at 37℃at 38℃at 39℃as shown in FIG. 6, and that 37℃was selected as the reaction temperature.
The primers were diluted to 10. Mu. Mol/L, the reaction temperature was 37℃and the amount of the primers was determined to be 3. Mu.L (i.e., the final concentration was 0.6. Mu. Mol/L) at different primer concentrations (0.1. Mu. Mol/L, 0.2. Mu. Mol/L, 0.4. Mu. Mol/L, 0.6. Mu. Mol/L, 0.8. Mu. Mol/L) by adding 0.5. Mu. L,1. Mu. L, 2. Mu. L, 3. Mu. L, 4. Mu. L of forward and reverse primers to the reaction system, respectively, as shown in FIG. 7.
After the reaction system was completed at 37℃with 3. Mu.L of the primer, 1.5. Mu.L, 2. Mu.L, 2.5. Mu.L, 3. Mu.L, 3.5. Mu.L of magnesium acetate I was added, respectively, at a concentration of 8.4mmol/L,11.2mmol/L,14mmol/L,16.8mmol/L,19.6mmol/L,22.4mmol/L, and the gel electrophoresis showed that the band of the amplified product became brighter as the amount of magnesium acetate I increased, the band was brightest at 3. Mu.L of magnesium acetate I, and then darkened, as shown in FIG. 8, and the amount of magnesium acetate I was determined to be 3. Mu.L (i.e., the final concentration was 16.8 mmol/L).
Cryptosporidium parvum RAA sensitivity assay:
the Cryptosporidium parvum plasmid standard is subjected to multiple dilution, and the concentration is selected to be 2.94 multiplied by 10 4 ~2.94×10 1 RAA amplification was performed using copy/. Mu.L as standard. Gel electrophoresis results showed that RAA was detectable at least 10 2 Copy/. Mu.L recombinant plasmid as shown in FIG. 9.
Cryptosporidium parvum RAA specificity experiments:
RAA amplification was performed using Cryptosporidium angustifolium, cryptosporidium parvum, cryptosporidium ruticosae, pichia pastoris, giardia duodenum, toxoplasma gondii, coccidium, bursaphelenchus and ascarial genomic DNA as templates, respectively, as shown in FIG. 10: only when Cryptosporidium parvum is used as a template, a single and brighter target band can be amplified, and other target bands are not amplified, so that the method has good specificity.
Example 3
A single RAA detection method for Cryptosporidium bovis and Cryptosporidium ruier is established
The amplification conditions of Cryptosporidium bovis and Cryptosporidium ruier RAA are optimized:
primers are designed aiming at the HSP70 gene locus (accession number: AY 741306) of the cryptosporidium bovis, wherein the upstream primer is 5 '-GAAGTCAAGGCAACCGCAGGTGATACTCAC-3', and the downstream primer is 5 '-ATAAAGTGGCACGGAAGTAATCGGAACAAA-3'. Primers are designed aiming at HSP70 gene locus (accession number: MZ 787790) of Cryptosporidium ruisii, wherein the upstream primer is 5 '-AGAAAGAATCGCGGAATGGATTTGACTACA-3', and the downstream primer is 5 '-CTCTACTGGAGATAAAGTGGCACGGAAGT-3'. The reaction temperature, primers and amount of magnesium acetate I were varied to determine the optimal amplification conditions for RAA. The reaction temperature was set in the PCR apparatus to 36℃at 37℃at 38℃at 39℃at 40℃at 41℃at 42℃respectively, and electrophoresis was carried out in 2% gel after the completion of the reaction, which revealed that the Cryptosporidium bovis band was brighter at 37℃at 38℃at 39℃at 40℃and, when the temperature continued to rise, the band began to darken, as shown in FIG. 11A, and 37℃was selected as the reaction temperature. Cryptosporidium ruinanensis has little difference in band at different temperatures, and 37 ℃ is selected as a reaction temperature as shown in FIG. 11B.
The primer was diluted to 10. Mu. Mol/L, the reaction temperature was 37℃and forward and reverse primers of 0.5. Mu.L, 1. Mu.L, 2. Mu.L, 3. Mu.L and 4. Mu.L were added to the above reaction system, respectively, and the gel electrophoresis result showed that the bands of Cryptosporidium bovis and Cryptosporidium angustifolium became clear as the amount of the primers increased, and that the sizes and the brightness of the bands were appropriate when the amount of the primers was 3. Mu.L, as shown in FIG. 12, and the amount of the primers was 3. Mu.L (i.e., the final concentration was 0.6. Mu. Mol/L).
After 3. Mu.L of the primer was measured at 37℃and the reaction system was used, 1.5. Mu.L, 2. Mu.L, 2.5. Mu.L, 3. Mu.L and 3.5. Mu.L of magnesium acetate I were added, respectively, at a concentration of 8.4mmol/L,11.2mmol/L,14mmol/L,16.8mmol/L,19.6mmol/L and 22.4mmol/L, respectively, and the gel electrophoresis results showed that the amplified product bands of Cryptosporidium bovis and Cryptosporidium angustifolium anki were not significantly changed with the increase of the amount of magnesium acetate I, and the results were all brighter, and as shown in FIG. 13, the amounts of Cryptosporidium bovis and Cryptosporidium angustifolium anki were determined to be 3. Mu.L (i.8 mmol/L, final concentration).
Bovine and Cryptosporidium Russian RAA sensitivity experiments:
subjecting Cryptosporidium bovis and Cryptosporidium ruii plasmid standard to multiple ratio dilution, respectively, and selecting Cryptosporidium bovis plasmid concentration of 2.64×10 4 ~2.64×10 1 RAA amplification was performed using copy/. Mu.L as standard, and gel electrophoresis showed that RAA could be detected at least 10 3 Copyingmu.L plasmid as shown in FIG. 14A. Cryptosporidium ruishii susceptibility test the selected concentration was 2.64×10 4 ~2.64×10 1 RAA amplification was performed using copy/. Mu.L plasmid as standard, and gel electrophoresis showed that RAA could be detected at least 10 3 Copy/. Mu.L plasmid as shown in FIG. 14B.
Bovine and Cryptosporidium Russian RAA specificity experiments:
in the cryptosporidium bovis RAA specificity experiment, the cryptosporidium angustiforme, cryptosporidium parvum, cryptosporidium ruici, pichia, giardia duodenalis, toxoplasma, coccidium, capillary nematodes and ascarial genome DNA are used as templates for carrying out RAA amplification respectively, and the result is shown in figure 15A, and the result shows that: the target band can be amplified only when Cryptosporidium bovis is used as a template, and other parasites do not amplify the target band, which proves that the method has good specificity.
In the cryptosporidium ruihni RAA specificity experiment, the genomic DNA of cryptosporidium angustiforme, cryptosporidium parvum, cryptosporidium nii, cryptosporidium parvum, pichia, giardia duodenum, toxoplasma, coccidium, capillary nematodes and roundworms is used as a template to carry out RAA amplification, as shown in figure 15B: only when Cryptosporidium Rugosae DNA is used as a template, a target band can be amplified, and other parasites do not amplify the target band, so that the method has good specificity.
Example 4
The method for detecting the double RAA of the cryptosporidium angustiforme and the cryptosporidium parvum is established:
the double RAA amplification conditions of Cryptosporidium angustifolium and Cryptosporidium parvum are optimized:
cryptosporidium parvum and Cryptosporidium parvum RAA primers were determined according to examples 1 and 2, and the optimal amplification reaction conditions of the double RNA were explored from the reaction temperature, the primers, and the amount of magnesium acetate I, respectively. The reaction system was first subjected to an amplification reaction at 36, 37, 38, 39, 40, 41, 42, 43℃and the gel electrophoresis results showed that both bands were brighter at 37, 38℃and then the target band was gradually darkened with increasing temperature, as shown in FIG. 16, with 37℃being selected as the optimal reaction temperature for the subsequent experiments.
In the exploration of the primer dosage, the study firstly selects 1:1 of primer pair dosage, namely 1 mu L of cryptosporidium parvum and cryptosporidium angustifolium primer, and the result shows that the target strip of the cryptosporidium angustifolium in the amplified strip is brighter than the cryptosporidium parvum, as shown in figure 17, and then selects the reduction of the amount of the cryptosporidium angustifolium primer and the increase of the amount of the cryptosporidium parvum primer to explore the optimal primer ratio dosage. The forward and reverse primers were added to the above reaction system at a primer concentration of 10. Mu. Mol/L and a reaction temperature of 37℃respectively (0.5. Mu.L, 1. Mu.L), (0.75. Mu.L, 1. Mu.L), (1. Mu.L, 1.25. Mu.L), (1. Mu.L, 1.5. Mu.L), (1.75. Mu.L), (1. Mu.L, 2. Mu.L), and the gel electrophoresis results showed that the amplification was best when the amount of the Cryptosporidium angustifolium primer was 1. Mu.L (i.e., the final concentration was 0.2. Mu. Mol/L) and the amount of the Cryptosporidium parvum primer was 1.75. Mu.L (i.e., the final concentration was 0.35. Mu. Mol/L), as shown in FIG. 18.
After the reaction system was added, 1.5. Mu.L, 2. Mu.L, 2.5. Mu.L, 3. Mu.L and 3.5. Mu.L of magnesium acetate I were added, respectively, i.e., the magnesium acetate concentrations were 8.4mmol/L,11.2mmol/L,14mmol/L,16.8mmol/L and 19.6mmol/L, respectively, and the gel electrophoresis results showed that the difference in the strip brightness of the amplified product was not large with the increase in the amount of magnesium acetate I, as shown in FIG. 19, the amount of magnesium acetate I was determined to be 3. Mu.L (i.e., the final concentration was 16.8 mmol/L).
Dual RAA sensitivity experiments:
the Cryptosporidium angustifolium plasmid and the Cryptosporidium parvum plasmid standard are subjected to double dilution, and 1 mu L of each is added to perform double RAA amplification. As a result, gel electrophoresis showed that at least 10 could be detected 3 Copy/. Mu.L of Cryptosporidium plasmid and Cryptosporidium parvum plasmid, the results are shown in FIG. 20.
Dual RAA specificity experiments:
amplification was performed using the genomic DNA mixture of cryptosporidium angustiforme and cryptosporidium parvum, cryptosporidium angustiforme, cryptosporidium nieri, cryptosporidium parvum, pichia, giardia duodenalis, toxoplasma, coccidium, capillary nematodes, roundworms, respectively, as templates, and the results are shown in fig. 21: the mixture of the genomic DNA of the cryptosporidium angustiforme and the genomic DNA of the cryptosporidium parvum can amplify the bands of two items, the target bands of the cryptosporidium angustiforme and the genomic DNA of the cryptosporidium parvum can be respectively amplified when the genomic DNA of the cryptosporidium angustiforme and the genomic DNA of the cryptosporidium parvum are respectively used as templates, and the target bands of other parasites are not amplified, so that the method has better specificity.
While there have been described and shown what are at present considered to be the primary examples of the experimental factors, it will be understood by those skilled in the art that various changes, modifications and combinations can be made therein without departing from the spirit and scope of the invention as defined in the appended claims and their equivalents.
Claims (7)
1. The establishment of four common cryptosporidium RAA detection methods is characterized in that: the method comprises the establishment of a single RAA detection method of four kinds of Cryptosporidium angustiforme, cryptosporidium parvum, cryptosporidium bovis and Cryptosporidium ranunculus, and the establishment of a dual RAA detection method of the Cryptosporidium angustiforme and the Cryptosporidium parvum.
2. The establishment of the RAA detection method according to claim 1, comprising the steps of:
s1: designing and synthesizing a primer;
s2: optimizing RAA amplification conditions;
s3: RAA sensitivity experiments;
s4: RAA specificity experiments.
3. The establishment of the RAA detection method according to claim 2, wherein: primers for each cryptosporidium:
for cryptosporidium angustifolium:
an upstream primer: 5 '-CCGTGCTTTGAGAAGATTAAGAACCCAGTG-3'; SEQ ID NO.1;
a downstream primer: 5 '-ACCTGCTGTTTCCAAACCTAAAGATAGTGG-3'; SEQ ID NO.2;
for cryptosporidium parvum:
an upstream primer: 5 '-AAACTAATGCGAAAGCATTTGCCAAGGATG-3'; SEQ ID NO.3;
a downstream primer: 5 '-AAACTAATGCGAAAGCATTTGCCAAGGATG-3'; SEQ ID NO.4;
for Cryptosporidium bovis:
an upstream primer: 5 '-GAAGTCAAGGCAACCGCAGGTGATACTCAC-3'; SEQ ID NO.5;
a downstream primer: 5 '-ATAAAGTGGCACGGAAGTAATCGGAACAAA-3'; SEQ ID NO.6;
for Cryptosporidium ruishii:
an upstream primer: 5 '-AGAAAGAATCGCGGAATGGATTTGACTACA-3'; SEQ ID NO.7;
a downstream primer: 5 '-CTCTACTGGAGATAAAGTGGCACGGAAGT-3'. The method comprises the steps of carrying out a first treatment on the surface of the SEQ ID NO.8.
4. The establishment of the RAA detection method according to claim 1, wherein: the temperature after optimizing the conditions of the amplification system is selected to be 37 ℃, the addition amount of the primer is 3 mu L, the final concentration is 0.6 mu mol/L, 3 mu L of magnesium acetate I is taken, and the final concentration is 16.8mmol/L.
5. The establishment of the RAA detection method according to claim 1, wherein: plasmid concentration in the single RAA assay established sensitivity experiments was: cryptosporidium angustifolium 10 3 Multiple copies, cryptosporidium parvum 10 2 Multiple copies, cryptosporidium bovis 10 3 Multiple copies, cryptosporidium ruier 10 3 Copy number; plasmid concentration in the dual RAA assay established sensitivity experiments was: cryptosporidium angustifolium and Cryptosporidium parvum are both 10 3 And copies.
6. The establishment of the double RAA detection method for the cryptosporidium angustiforme and cryptosporidium parvum is characterized in that: cryptosporidium angustifolium and Cryptosporidium parvum are selected as the establishment of a dual RAA detection method for researching target sequences.
7. The method for dual RAA detection according to claim 6, wherein: primers in the single RAA detection method of the cryptosporidium angustiforme and the cryptosporidium parvum are selected, and the establishment of the double RAA detection method is carried out respectively from the experiments of optimizing amplification conditions, sensibility and specificity.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311080419.8A CN116949197A (en) | 2023-08-25 | 2023-08-25 | Establishment of four common cryptosporidium RAA detection methods |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311080419.8A CN116949197A (en) | 2023-08-25 | 2023-08-25 | Establishment of four common cryptosporidium RAA detection methods |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116949197A true CN116949197A (en) | 2023-10-27 |
Family
ID=88458492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311080419.8A Pending CN116949197A (en) | 2023-08-25 | 2023-08-25 | Establishment of four common cryptosporidium RAA detection methods |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116949197A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117568501A (en) * | 2024-01-15 | 2024-02-20 | 深圳市刚竹医疗科技有限公司 | Primer probe combination, kit and method for detecting snake-source cryptosporidium based on real-time fluorescence quantitative PCR technology |
-
2023
- 2023-08-25 CN CN202311080419.8A patent/CN116949197A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117568501A (en) * | 2024-01-15 | 2024-02-20 | 深圳市刚竹医疗科技有限公司 | Primer probe combination, kit and method for detecting snake-source cryptosporidium based on real-time fluorescence quantitative PCR technology |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102605055B (en) | Multiplex quantitative PCR (polymerase chain reaction) detection kit for vibrio parahaemolyticus and detection method | |
CN103320434B (en) | Salmonella LAMP (loop-mediated isothermal amplification) primer group and kit and detection method | |
CN106957927A (en) | African swine fever fluorescence PCR detection reagent, African swine fever fluorescence PCR detection reagent kit and its application | |
CN105400778B (en) | The kit and detection method of 10 kinds of kinds of pathogenic vibrio are detected simultaneously | |
CN110616272B (en) | Primer group for detecting prawn liver enterocytozoon and kit containing primer group | |
CN109913565B (en) | Kit, primer pair, probe and method for detecting vibrio parahaemolyticus | |
CN116949197A (en) | Establishment of four common cryptosporidium RAA detection methods | |
CN106520923B (en) | Kit and method for simultaneously detecting staphylococcus aureus and 5 enterotoxins thereof | |
CN102816847A (en) | LAMP primer for detecting Brucella and kit containing the same | |
CN114774565A (en) | Kit and method for visually detecting trichomonas vaginalis based on RPA-CRISPR-Cas12a system | |
WO2006043349A1 (en) | Method of detecting influenza bacillus, primer set for detection of influenza bacillus and kit for detection of influenza bacillus | |
Wang et al. | Simultaneous visual diagnosis of acute hepatopancreatic necrosis disease and Enterocytozoon hepatopenaei infection in shrimp with duplex recombinase polymerase amplification | |
CN109439801A (en) | A kind of honeybee Israel acute paralysis virus real-time fluorescent RT-PCR detection reagent box and its detection method | |
CN110982916B (en) | Primer combination and detection kit for detecting shiga toxin-producing escherichia coli | |
Lei et al. | Duplex detection of Vibrio cholerae and Vibrio parahaemolyticus by real-time recombinase polymerase amplification | |
CN107385089B (en) | Nucleic acid combination, kit and method for detecting cryptosporidium oocysts | |
CN113943822B (en) | LAMP-LFD-based helicobacter pylori POCT detection kit and method | |
CN110878380B (en) | Primer composition, kit and method for detecting vesicular stomatitis virus Indiana type and new Jersey type | |
KR102009326B1 (en) | DEVELOPMENT OF SINGLEPLEX REAL-TIME PCR KIT FOR RAPID DETECTION OF CLOSTRIDIUM PERFRINGENS USING cpa, cpe TARGET GENE | |
WO2005030027A2 (en) | Salmonella detection identification | |
KR102076343B1 (en) | Composition for detecting adenovirus type 55 using Real-time LAMP and uses thereof | |
CN113832241A (en) | Probe, primer group, kit and detection method for rapidly detecting aeromonas salmonicida through RPA-LFS | |
CN113151496A (en) | Primer, probe, kit and method for visual rapid detection of schistosoma mansoni nucleic acid by LFD-RPA | |
CN107227378B (en) | RPA-IAC primer and method for detecting vibrio mimicus | |
CN112195257A (en) | Primer group, reagent, kit and detection method for detecting vibrio parahaemolyticus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication |